First class is largely filled with corporate customers, but many deep-pocket individuals are willing to pay up as they demand ...

JMP Securities analyst Constantine Davides lowered the firm’s price target on AMN Healthcare (AMN) to $47 from $57 and keeps an ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Truist lowered the firm’s price target on AMN Healthcare (AMN) to $47 from $50 and keeps a Buy rating on the shares. The company reported mixed Q3 results and issued downside Q4 guidance as EBITDA ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

Data show SBT101 effectively delivered a functional copy of the ABCD1 gene to spinal cord tissues with resultant protein expression, addressing the underlying cause of disease and improving function ...

AMN Healthcare Services, Inc. (NYSE: AMN) launched an innovative technology suite, WorkWise, last Wednesday. The suite is expected to unify the company's technologies into one single technology ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities across the nation. Its workforce solutions include managed services programs ...